Cat.#: ACPP-1333
| Despition | Nurr1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1744 | Human C1q Protein (AC1744) | 200 µg | inquiry |
| ACPP-1224 | LAMP1 Blocking Peptide (AC1224) | 250 µg | inquiry |
| ACPP-1689 | Human DUSP26 Protein (AC1689) | 5 µg | inquiry |
| ACPP-1389 | AHSG (AC1389) | 10 µg | inquiry |
| ACPP-1277 | TSH beta Blocking Peptide (AC1277) | 250 µg | inquiry |
| ACPP-1762 | Human SNAP25 Protein, His (AC1762) | 10 µg | inquiry |
| ACPP-1765 | Human PQBP1 Protein (AC1765) | 5 µg | inquiry |
| ACPP-1747 | Human TSG Protein (AC1747) | 10 µg | inquiry |
| ACPP-1335 | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide (AC1335) | 250 µg | inquiry |
| ACPP-1154 | Recombinant Human FGF19 Protein (6×His Tag) (AC1154) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.